It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

HYKU Biosciences logo

HYKU Biosciences 

Laura Brass - Director
Adam Cotton - Observer

Boston, USA 

HYKU Biosciences is developing small-molecule covalent inhibitors targeting non-cysteine amino acids to address current challenges associated with many disease targets, including selectivity, druggability, and resistance.